Improve the chances of a successful pregnancy Workshop

15 April 2023, Republic of Singapore
October 2023, Europe (to be defined date and venue)
View on E-learning
scroll-down-icon

Overview

This educational activity will focus on the main aspects of IVF. The program will start with the low prognosis patients, focusing on the diagnostic assessment of the condition; then, the lectures will be focused on the treatments, mainly ART, defining the clinical applicability in the real-world activity of the new Poseidon criteria for low prognosis patients.

The program will take place in Asia Pacific and Europe and will engage renowned international and regional experts with vast clinical experience in constantly evolving subjects.

Learning Objectives

After attending the educational activities, learners will be able to:

  • • Define severe LH and FSH deficiency and patient management.
  • • Discuss and debate the management of low prognosis patients.
  • • Redefine PCO and management strategies.
  • • Comprehend the new low prognosis concept and its application in clinical practice.
  • • Individualize and manage women with expected or unexpected prognosis to ART as per the POSEIDON classification.
  • • Evaluate luteal phase supplementations in fresh and frozen cycles.
  • • Estimate pregnancy outcomes in the freeze-all strategy.

Target Audience

The program is intended for clinicians, embryologists, andrologists, scientists, and managers working in ART who wish to update their knowledge of advanced techniques and scientific innovations and understand best practices using evidence-based models of care.

Accreditation

This program will be submitted for CME accreditation to EACCME® (European Accreditation Council for Continuing for Medical Education).

Language

The official language of the activity will be English. 

Improve the chances of a successful pregnancy Workshop

From Asia Pacific to Europe

15 April 2023 Singapore, Republic of Singapore

October 2023, Europe  (dates and venue to be defined)

Contact us for registration

Language

The official language of the activity will be English.
eng

Date & Venue

15 April 2023
SINGAPORE
NATIONAL UNIVERSITY HOSPITAL
1E Kent Ridge Road, Level 12, Singapore 119228

October 2023 (date and venue to be announced) Europe

Accreditation

This program will be submitted for CME accreditation to EACCME® (European Accreditation Council for Continuing for Medical Education).

Registration

For registration, dinner, accommodation and any logistic inquiry, please contact:

info@medeaacademy.com

Registration fee:

200.00€* (VAT excluding)
The registration includes:
• Scientific sessions
• Coffee breaks and lunch
• Educational materials
• Certificate of attendance


100.00€* (VAT excluding)
Reduced fees for residents and fellows in training
*Dinner is not included

Chairs

Carlo Alviggi

Federico II University
Naples, Italy
Biography

Sandro C. Esteves

Androfert - Andrology and Human Reproduction Clinic
Campinas, Brazil
Biography

Robert Fisher

Fertility Centre Hamburg
Hamburg, Germany
Aarhus, Denmark
Biography

Peter Humaidan

Skive Regional Hospital and Faculty of Health
Aarhus University
Fertility Clinic
Skive, Denmark
Biography

Peng Cheang Wong

Yong Loo Lin School of Medicine National University of Singapore National University Health System Singapore, Republic of Singapore
Biography

Scientific Program

PDF Available soon

Topics

Funding

Our educational activities are supported by an independent grant from the Healthcare business of Merck KGaA, Darmstadt, Germany; and additional support from FUJIFILM EUROPE GMBH, Fujifilm Italia S.p.A., FUJIFILM France S.A.S.

· Carlo Alviggi ·

Carlo Alviggi earned his MD degree in 1994, from the Faculty of Medicine of the University of Naples “Federico II” in Naples, Italy; he specialized in obstetrics and gynaecology in 1998, and gained a PhD in 2001, from the same university. During his career, he collaborated with: The Imperial College of London, in London, UK; the Laboratory of Immunology of the Italian National Research Council in Naples; and the Autoimmunity and Tolerance Laboratory of the University of California in Los Angeles, CA, USA. This network resulted in various publications, some of which concern new hypotheses on the pathogenesis of pelvic endometriosis. He is now an associate professor in reproductive medicine at the Fertility Unit of the University of Naples “Federico II”. Professor Alviggi’s current research interests are the role of luteinizing hormone (LH) in folliculogenesis; the use of LH-containing drugs in patients undergoing ovarian controlled stimulation for IVF; the pathogenesis of pelvic endometriosis; oncofertility; reproductive endicrinology and the genetics of human reproduction. He has participated in several national and international (phase 2 and 3) multicentric, prospective randomized trials. Professor Alviggi has published extensively and has been invited to lecture at over 200 international meetings dealing with reproductive medicine and gynaecological endocrinology; he is also starter and co-founder of the Poseidon group, an international collaborative network dedicated to low prognosis patients in Assisted Reproductive Technology and vice-President of the “Società Italiana di Fertilità e Sterilità – Medicina della Riproduzione”.

· Sandro C. Esteves ·

Sandro Esteves, MD., Ph.D. is a board-certified urologist and consultant in assisted reproduction with over 25 years of clinical experience in all areas of reproductive medicine, with specialization in male reproduction.

He is listed by Expertscape among the top three world experts in the areas of male infertility, azoospermia, varicocele, and sperm retrieval techniques. Sandro has been also included in the list of the world’s most influential scientists.

He is the Founder and Medical Director of the ANDROFERT Andrology & Human Reproduction Clinic, in Campinas, Brazil. Dr. Esteves established the first Brazilian Fertility Clinic with a primary focus on male infertility, as well as the very first to introduce quality management as per the ISO 9001 standards and IVF cleanroom technology (ISO 14644-1).

Sandro is also a Collaborating Professor of Urology at the University of Campinas (UNICAMP, Brazil) and Honorary Professor of Reproductive Medicine at Aarhus University (Denmark). Dr. Esteves received his Master’s in Surgery from the University of Campinas Medical School and his Ph.D. in Urology from the Federal University of São Paulo Medical School. His post-doctoral training was at the American Center for Reproductive Medicine at the Cleveland Clinic in the United States. He has received many research grants and awards from national and international societies.

Prof. Esteves is the author of 10 textbooks in the fields of infertility and reproductive medicine. He was also the co-editor of several Journal Supplements and has published over 400 hundred scientific papers in journals like Lancet, Nature, Human Reproduction Update, Human Reproduction, Fertility and Sterility, etc. His current Hirsch index (h-index) is 63 while his citation count is over 12K. He is a member of ‘Faculty Opinions’ in the area of reproductive endocrinology & infertility. Dr. Esteves is Associate Editor of Frontiers in Endocrinology (Reproduction), Andrology, International Brazilian Journal of Urology, Regional Editor of the Société Internationale d’Urologie Journal, an editorial board member of Nature Reviews Urology, and a dozen of other peer-reviewed scientific journals. He is also a co-founder of the POSEIDON group and currently serves as a Chair of the Male Infertility Section of the WHO Infertility Guidelines Development Group.

Dr. Esteves is a very much requested speaker and presents over 50 lectures annually. He also regularly conducts infertility workshops, provides consulting services in the area of quality management for ART Clinics,

· Robert Fischer ·

Robert Fischer is the founder and Medical Director of the Fertility Center Hamburg (FCH) in Hamburg, Germany. Dr Fischer trained in obstetrics and gynaecology at the University Hospital of Münster, Germany, from 1979 to 1982 and at the Queen’s Medical Centre, University of Nottingham, UK. In 1983, Dr Fischer pioneered the first German outpatient IVF unit in Hamburg and became its Medical Director. The unit moved to a new location in 1998, and its name was changed to the “Fertility Center Hamburg”.

In July 1998, the Fertility Center Hamburg was one of the first centres, both in Germany and worldwide, to introduce quality management, and it was certified according to the ISO 9001 and accredited for IVF laboratories (ISO 17025). Dr Fischer’s main research interests are in the development of stimulation protocols, luteinizing hormone supplementation, and gonadotropin-releasing hormone agonist triggering, as well as further development of quality management systems in IVF centres. He is a founding member of the European Society of Human Reproduction and Embryology (ESHRE); a founding member of the POSEIDON (Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number) group);  Member of the  Scientific Committee of Excellence in Medical Education (EXCEMED- formerly the Serono Symposia International Foundation) and Scientific director of  Med.E.A.( Medical Education Academy)

· Peter Humaidan ·

Professor Peter Humaidan is a specialist in reproductive endocrinology, professor at The Fertility Clinic Skive Regional Hospital, Aarhus University, Denmark and Honorary professor at Odense University, Denmark. During his scientific work he has primarily focused on developing individualized treatment protocols for the infertile patient. His doctoral thesis (DMSc) explored the role of LH during the follicular and luteal phases in controlled ovarian stimulation. His main fields of interest are triggering of ovulation with GnRH agonist, role of LH during the follicular and luteal phases, role of the female genital tract microbiota for reproductive outcomes, OHSS prevention, and role of sperm DNA fragmentation for spontaneous and assisted reproduction. He is the founder of the international society “The Copenhagen GnRHa Triggering Workshop Group” who introduced the GnRHa trigger in modern IVF, changing trigger policies worldwide. Moreover, he is co-founder of the POSEIDON group which suggested a new stratification of the poor responder patient, and a past board member of the ESHRE SIG Endocrinology Group. He is in the Elsevier, Stanford global list of 2% top scientists, and he authored and co-authored 250 + articles (H-index 67, Google Scholar) in international peer reviewed journals as well as chapters in textbooks and the Danish guidelines for OHSS prevention. Peter Humaidan has a wide international scientific network and is frequently invited as a speaker at international conferences. 

· Peng Cheang Wong ·

Peng Cheang Wong is the Professor of Obstetrics & Gynaecology in the Yong Loo Lin School of Medicine and a Senior Consultant in the National University Hospital. He was the Head of the Division of Reproductive

Endocrinology & Infertility in the National University Hospital from 2001 to 2017 and the Director of the Assisted Reproductive Technologies (ART) Programme in the National University Hospital, Singapore. He was also the founding Director of the Centre for Reproductive Education & Specialist Training (CREST) until 2017 and the first President of the Asia-Pacific Initiative on Reproduction (ASPIRE) from 2006 – 2008. He is active in postgraduate education in the field of ART and has conducted and participated in numerous courses in the region.